Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Pancreatic cancer
Closed
Phase 3
This trial is looking at olaparib for pancreatic cancer that has spread. It is open to people whose pancreatic cancer has an change in or .
Recruitment start: 16 December 2014
Recruitment end: 15 January 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Daniel Hochhauser
AstraZeneca
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
PAREXEL
Last reviewed: 15 January 2019
CRUK internal database number: 13023
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
